Case Study: Umbilical Cord Blood Transplant Rescues Young Leukaemia Patient

A groundbreaking treatment has saved the life of a young girl battling leukaemia, offering hope to those for whom conventional options have failed. Sarah, an eight-year-old from Cornwall, participated in a two-year clinical trial at the Royal Manchester Children's Hospital, marking her "last chance to survive," according to her mother, Simona.

Sarah's journey began at the age of four when diagnosed with acute myeloid leukaemia. Despite undergoing various treatments, including chemotherapy and a bone marrow transplant, none proved successful. The hospital's innovative trial introduced a novel approach – a cord blood stem cell transplant using blood from donated umbilical cords.

The trial, involving 10 children, combined the cord blood transplant with white blood cell transfusions, aiming to enhance the cancer-fighting capabilities of the new cord blood. This treatment is typically reserved for cases where all other options have been exhausted due to associated risks.

Simona expressed her gratitude, noting that the trial was the "last chance of life" for Sarah. A year into remission, Sarah is now "fully enjoying life," and the family looks forward to a holiday in France. Simona emphasized the transformative impact of the treatment, stating, "This treatment has given us all our lives back."

Published in the British Journal of Haematology, initial results from the study have prompted the expansion of the trial to recruit more patients from across the UK. Prof Rob Wynn, the director of the paediatric bone marrow transplant program at the hospital, highlighted that five children, including Sarah, achieved remission through the experimental treatment.

Prof Wynn emphasized the critical role of cord blood cells, stating that they offer the most effective treatment for hard-to-treat blood cancers in children. The success of the clinical trial is a testament to this approach, providing a lifeline for the sickest children with limited treatment options.

The hospital aims to continue refining and optimizing the treatment based on further research, paving the way to cure children facing difficult-to-treat leukaemia. The success stories emerging from this breakthrough offer renewed hope for those grappling with challenging medical conditions and underscore the potential of innovative treatments in transforming lives.

‍

Source: https://www.bbc.com/news/uk-england-manchester-65960349?fbclid=IwAR1V2s1n65PHeVK0uck2w5H75S-Qp46c4kbzkQY6ltyq4kcHAiUMCjNiIIU

‍